Correlation Between CTi Biopharma and Ocuphire Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CTi Biopharma and Ocuphire Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CTi Biopharma and Ocuphire Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CTi Biopharma Corp and Ocuphire Pharma, you can compare the effects of market volatilities on CTi Biopharma and Ocuphire Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CTi Biopharma with a short position of Ocuphire Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CTi Biopharma and Ocuphire Pharma.

Diversification Opportunities for CTi Biopharma and Ocuphire Pharma

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between CTi and Ocuphire is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding CTi Biopharma Corp and Ocuphire Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocuphire Pharma and CTi Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CTi Biopharma Corp are associated (or correlated) with Ocuphire Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocuphire Pharma has no effect on the direction of CTi Biopharma i.e., CTi Biopharma and Ocuphire Pharma go up and down completely randomly.

Pair Corralation between CTi Biopharma and Ocuphire Pharma

If you would invest  909.00  in CTi Biopharma Corp on September 13, 2024 and sell it today you would earn a total of  0.00  from holding CTi Biopharma Corp or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy3.23%
ValuesDaily Returns

CTi Biopharma Corp  vs.  Ocuphire Pharma

 Performance 
       Timeline  
CTi Biopharma Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CTi Biopharma Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound forward indicators, CTi Biopharma is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Ocuphire Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ocuphire Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. Even with inconsistent performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

CTi Biopharma and Ocuphire Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CTi Biopharma and Ocuphire Pharma

The main advantage of trading using opposite CTi Biopharma and Ocuphire Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CTi Biopharma position performs unexpectedly, Ocuphire Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocuphire Pharma will offset losses from the drop in Ocuphire Pharma's long position.
The idea behind CTi Biopharma Corp and Ocuphire Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Global Correlations
Find global opportunities by holding instruments from different markets
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Bonds Directory
Find actively traded corporate debentures issued by US companies